Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    May 2018
  1. YAMAMOTO CM, Murakami T, Oakes ML, Mitsuhashi M, et al
    Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Am J Nephrol. 2018;47:283-291.
    PubMed     Text format     Abstract available


    January 2018
  2. CHIN MP, Bakris GL, Block GA, Chertow GM, et al
    Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
    Am J Nephrol. 2018;47:40-47.
    PubMed     Text format     Abstract available


  3. TRIEBSWETTER S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, et al
    Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Am J Nephrol. 2018;47:30-39.
    PubMed     Text format     Abstract available


    December 2017
  4. JARDINE MJ, Mahaffey KW, Neal B, Agarwal R, et al
    The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.
    Am J Nephrol. 2017;46:462-472.
    PubMed     Text format     Abstract available


  5. NEUMILLER JJ, Rhee CM, Kalantar-Zadeh K
    Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.
    Am J Nephrol. 2017;46:459-461.
    PubMed     Text format    


    September 2017
  6. SAULNIER PJ, Dieter BP, Tanamas SK, McPherson SM, et al
    Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Am J Nephrol. 2017;46:276-284.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: